Skip to main content
logo
Lakefront Biotherapeutics NV (LKFT)
NASDAQ: LKFT · Real-Time Price · USD
29.36
+1.37 (4.89%)
At close: Aug 19, 2026, 4:00 PM EDT
29.19
-0.17 (-0.58%)
Pre-market: Aug 20, 2026, 7:56 AM EDT

LKFT Financials Overview

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
990.551,112275.65239.72241.25234.38
Revenue Growth
259.40%303.50%14.99%-0.63%2.93%-50.97%
Gross Profit
727.39623.09-94.67-1.57-28.55-86.12
Operating Income
643.78535.28-187.1-85.11-131.06-171.57
Net Income
596.58320.8874.08211.7-217.99-103.23
Earnings Per Share
9.024.871.123.21-3.32-1.58
EPS Growth
-333.66%-65.05%---

Revenue by Geography
Chart
Fiscal YearFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Dec '22 Dec '21
United States of America
1,081240.79239.71241.15234.34
Europe
31.134.860.020.10.04
Total
1,112275.65239.72241.25234.38

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
2,9822,9983,1183,6854,0944,703
Total Debt
6.446.9211.729.621.926.86
Net Cash (Debt)
2,9762,9913,1063,6754,0724,676
Net Cash Growth
-3.48%-3.69%-15.48%-9.75%-12.92%-8.88%
Net Cash Per Share
44.9945.3947.1055.7461.9871.39

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
--257.46-320.03-405.97-500.54-503.83
Capital Expenditures
--13.7-16.72-18.71-27.39-54.21
Free Cash Flow
--271.16-336.75-424.68-527.93-558.03
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
73.43%56.02%-34.34%-0.66%-11.83%-36.74%
Operating Margin
64.99%48.13%-67.87%-35.50%-54.32%-73.20%
Pretax Margin
58.31%27.05%-1.12%2.35%-29.37%-50.94%
Profit Margin
60.23%28.85%26.88%88.31%-90.36%-44.04%
FCF Margin
--24.38%-122.16%-177.15%-218.83%-238.09%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
2.865.7523.5911.51--
PS Ratio
1.721.666.3410.1711.2813.77